Faculty, Lecturers and Instructors
Many DKFZ laboratories are incorporated into our innovative Major "Cancer Biology" Program. This allows the students to experience cutting edge science and to interact with internationally leading scientists at a very early stage of their career.
The lists of lecturers and instructors from the various Research Divisions and Groups, who are actively involved in the Major Cancer Biology study program, are arranged according to the DKFZ Research Programs (Forschungsschwerpunkte)
Prof. Dr. Peter ANGEL, Division of Signal Transduction and Growth Control (A100) E-mail
Prof. Dr. Hellmut AUGUSTIN, Division of Vascular Oncology and Metastasis (A190) E-mail
Dr. Susanne BARTELS, Division of Vascular Oncology and Metastasis (A190) E-mail
Prof. Dr. Petra BOUKAMP, Division of Genetics of Skin Carcinogenesis (A110) E-mail
Dr. Achim BREILING, Division of Epigenetics (A130) E-mail
Dr. Lorenza D'ALESSANDRO, Division of Systems Biology of Signal Transduction (A150) E-mail
PD Dr. Tobias DICK, Division of Redox Regulation (A160) E-mail
Dr. Andreas FISCHER, Division of Vascular Oncology and Metastasis (A190) E-mail
Dr. Karin GREULICH-BODE, Division of Genetics of Skin Carcinogenesis (A110) E-mail
Prof. Dr. Stephan HERZIG, Division of Molecular Metabolic Control (A170) E-mail
PD Dr. Jochen HESS, Division of Signal Transduction and Growth Control (A100) and DKFZ Junior Group Molecular Mechanisms of Head and Neck Tumors (A102), NCT, and Heidelberg University Hospital E-mail
Prof. Dr. Ilse HOFMANN, Division of Vascular Oncology and Metastasis (A190) E-mail
Prof. Dr. Ursula KLINGMÜLLER, Division of Systems Biology of Signal Transduction (A150) E-mail
Prof. Dr. Frank LYKO, Division of Epigenetics (A130) E-mail
Prof. Dr. Doris MAYER, Research Group Hormones and Signal Transduction (A105) E-mail
Dr. Bruce MORGAN, Division of Redox Regulation (A160) E-mail
PD Dr. Karin MÜLLER-DECKER, Core Facility Tumor Models (W420), E-mail
Dr. Christoph RÖSLI, Division of Stem Cells and Cancer (A010) and HI-STEM E-mail
Dr. Marcel SCHILLING, Division of Systems Biology of Signal Transduction (A150) E-mail
Dr. Marina SCHORPP-KISTNER, Division of Signal Transduction and Growth Control (A100) E-mail
Dr. Georg STÖCKLIN, Helmholtz Junior Research Group Posttranscriptional Control of Gene Expression (A200) E-mail
Prof. Dr. Andreas TRUMPP, Division of Stem Cells and Cancer (A010) and HI-STEM E-mail
Dr. Alexandros VEGIOPOULOS, Division of Molecular Metabolic Control (A170) E-mail
PD Dr. Renate VOIT, Division of Molecular Biology of the Cell II (A030) E-mail
Prof. Dr. Michael BOUTROS, Division Signaling and Functional Genomics (B110) E-mail
Dr. Sven DIEDERICHS. Junior Research Group Molecular RNA Biology and Cancer (B150) E-mail
Dr. Maria FÄLTH, Research Group Cancer Genome Research (B063) E-mail
Dr. Frank GÖTSCHEL, Division of Molecular Genome Analysis (B050) E-mail
Prof. Dr. Harald HERRMANN-LERDON, Research Group Functional Cell Biology (B065) E-mail
Dr. Tore KEMPF, Research Group Functional Proteome Analysis (B100) E-mail
Dr. Ulrike KORF, Division of Molecular Genome Analysis (B050) E-mail
Dr. Dominique KRANZ, Division Signaling and Functional Genomics (B110) E-mail
Dr. Ruprecht KUNER, Research Group Cancer Genome Research (B063) E-mail
Prof. Dr. Jörg LANGOWSKI, Division of Biophysics of Macromolecules (B040) E-mail
Prof. Dr. Peter LICHTER, Division of Molecular Genetics (B060) E-mail
Dr. Norbert MÜCKE, Division of Biophysics of Macromolecules (B040) Contact Form
Dr. Violaine ROSENSTIEL-GOIDTS, Division of Molecular Genetics (B060) E-mail
Dr. Özgür SAHIN, Division of Molecular Genome Analysis (B050) E-mail
Dr. Martina SCHNÖLZER, Research Group Functional Proteome Analysis (B100) E-mail
PD Dr. Holger SÜLTMANN, Research Group Cancer Genome Research (B063) and NCT E-mail
Dr. Aurelio TELEMAN, Helmholtz Junior Research Group Signal Transduction in Cancer and Metabolism (B140) E-mail
Dr. Katalin TOTH, Division of Biophysics of Macromolecules (B040) E-mail
Dr. Frank WESTERMANN, Division of Tumor Genetics (B030) E-mail
PD Dr. Stefan WIEMANN, Division of Molecular Genome Analysis (B050) E-mail
Dr. Clarissa GERHÄUSER, Division of Epigenomics and Cancer Risk Factors (C010) E-mail
Prof. Dr. Wolfgang HAGMANN, Division of Epigenomics and Cancer Risk Factors (C010) E-mail
Prof. Dr. Rudolf KAAKS, Division of Cancer Epidemiology (C020) E-mail
Prof. Dr. Rajiv KUMAR, Division of Molecular Genetic Epidemiology (C050) E-mail
PD Dr. Justo LORENZO BERMEJO, Institute of Medical Biometry and Informatics (IMBI), University Hospital Heidelberg E-mail
Prof. Dr. Christoph PLASS, Division of Epigenomics and Cancer Risk Factors (C010) E-mail
PD Dr. Odilia POPANDA, Division of Epigenomics and Cancer Risk Factors (C010) E-mail
PD Dr. Angela RISCH, Division of Epigenomics and Cancer Risk Factors (C010) E-mail
PD Dr. Heinz SCHMEISER, Research Group Genetic Alterations in Carcinogenesis (C016) E-mail
Dr. Peter SCHMEZER, Division of Epigenomics and Cancer Risk Factors (C010) E-mail
Dr. Dieter WEICHENHAN, Division of Epigenomics and Cancer Risk Factors (C010) E-mail
Prof. Dr. Peter ALTEVOGT, Division of Translational Immunology (D015) E-mail
Prof. Dr. Bernd ARNOLD, Division of Molecular Immunology (D050) E-mail
Prof. Dr. Philipp BECKHOVE, Division of Translational Immunology (D015) and NCT E-mail
PD Dr. Adelheid CERWENKA, Boveri Junior Research Group Innate Immunity (D080) E-mail
Dr. Jens DERBINSKI, Division of Developmental Immunology (D090) E-mail
Prof. Dr. Stefan EICHMÜLLER, Division of Translational Immunology (D015) Contact Form
Dr. Markus FEUERER, Helmholtz Junior Research Group Immune Tolerance (D100) E-mail
Dr. Thorsten FEYERABEND, Division of Cellular Immunology (D110) E-mail
Prof. Dr. Peter KRAMMER, Division of Immunogenetics (D030) E-mail
Prof. Dr. Bruno KYEWSKI, Division of Developmental Immunology (D090) E-mail
PD Dr. Inna LAVRIK, Division of Immunogenetics (D030) E-mail
Dr. Gerhard MOLDENHAUER, Division of Translational Immunology (D015) and NCT E-mail
PD Dr. Frank MOMBURG, Division of Translational Immunology (D015) and NCT E-mail
Dr. Wolfram OSEN, Division of Translational Immunology (D015) Contact Form
Prof. Dr. Hans-Reimer RODEWALD, Division of Cellular Immunology (D110) E-mail
Dr. Alexander RÖLLE, Boveri Junior Research Group Innate Immunity (D080) E-mail
PD Dr. Reinhard SCHWARTZ-ALBIEZ, Division of Translational Immunology (D015) E-mail
Prof. Dr. Viktor UMANSKY, Clinical Cooperation Unit for Dermato-Oncology (G300) E-mail
Dr. Dr. Amir ABDOLLAHI, Junior Research Group Molecular Radiooncology (E210) E-mail
Prof. Dr. Peter BACHERT, Division of Medical Physics in Radiology (E020) E-mail
Dr. Soenke BARTLING, Division of Medical Physics in Radiology (E020) E-mail
PD Dr. Tobias BÄUERLE, Division of Medical Physics in Radiology (E020) E-mail
Dr. Peter HÄRING, Division of Medical Physics in Radiation Oncology (E040) E-mail
Dr. Ute HENNRICH, Division of Medical Physics in Radiology (E020) E-mail
Dr. Jürgen JENNE, Clinical Cooperation Unit Radiation Oncology (E050) E-mail
Dr. Dorde KOMLJENOVIC, Division of Medical Physics in Radiology (E020) E-mail
Dr. Frederik LAUN, Division of Medical Physics in Radiology (E020) E-mail
Dr. Simeon NILL, Division of Medical Physics in Radiation Oncology (E040) Contact Form
Prof. Dr. Uwe OELFKE, Division of Medical Physics in Radiation Oncology (E040) E-mail
Dr. Jörg PETER, Division of Medical Physics in Radiology (E020) E-mail
Dr. Bernhard RHEIN, Division of Medical Physics in Radiation Oncology (E040) E-mail
Prof. Dr. Wolfgang SCHLEGEL, Division of Medical Physics in Radiation Oncology (E040) E-mail
Dr. Andrea SCHWAHOFER, Division of Medical Physics in Radiation Oncology (E040) E-mail
Prof. Dr. Dr. Wolfhard SEMMLER, Division of Medical Physics in Radiology (E020) E-mail
Prof. Dr. Valerie BOSCH, Division of Genome Modifications and Carcinogenesis (F020) E-mail
Prof. Dr. Henri-Jacques DELECLUSE, Division of Pathogenesis of Virus Associated Tumors (F100) E-mail
Dr. habil. Christiane DINSART, Division of Tumor Virology (F010) E-mail
Dr. Regina FEEDERLE, Division of Pathogenesis of Virus Associated Tumors (F100) E-mail
Prof. Dr. Lutz GISSMANN, Division of Genome Modifications and Carcinogenesis (F020) E-mail
Dr. Dirk GRIMM, CellNetworks Research Group Virus Host Interactions, Bioquant, University of Heidelberg E-Mail
Prof. Dr. Jürgen KLEINSCHMIDT, Division of Tumor Virology (F010) E-mail
Prof. Dr. Martin LÖCHELT, Division of Genome Modifications and Carcinogenesis (F020) E-mail
Dr. Antonio MARCHINI, Division of Tumor Virology (F010) E-mail
Prof. Dr. Martin MÜLLER, Research Group Tumorvirus-Specific Vaccination Strategies (F035) E-mail
PD Dr. Dirk NETTELBECK, Helmholtz-University-Junior Research Group Oncolytic Adenoviruses (F110) E-mail
Dr. Jürg NÜESCH, Division of Tumor Virology (F010) E-mail
Dr. Michael PAWLITA, Division of Genome Modifications and Carcinogenesis (F020) E-mail
PD Dr. Anne RÉGNIER-VIGOUROUX, Division of Tumor Virology (F010) E-mail
PD Dr. Dr. Angelika RIEMER, Junior Research Group Immunotherapy and -prevention (F130) E-mail
Prof. Dr. Jean ROMMELAERE, Division of Tumor Virology (F010) E-mail
Dr. Nathalie SALOMÉ, Division of Tumor Virology (F010) E-mail
Prof. Dr. Elisabeth SCHWARZ, Division of Viral Transformation Mechanisms (F030) E-mail
Prof. Dr. Rainer ZAWATZKY, Division of Viral Transformation Mechanisms (F030) E-mail
Dr. Claudia BALL, Division of Translational Oncology (G100) and NCT, E-mail
Dr. Cynthia BARTHOLOMÄ, Division of Translational Oncology (G100) and NCT E-mail
Dr. Sascha BOSSOW, Division of Translational Oncology (G100) and NCT E-mail
Dr. Richard GABRIEL, Division of Translational Oncology (G100) and NCT E-mail
Prof. Dr. Christof von KALLE, Division of Translational Oncology (G100), NCT Translational Oncology Section E-mail
Dr. Susanne KLEBER, Division of Neurobiology of Brain Tumors (G381) E-mail
PD Dr. Stephanie LAUFS, Division of Translational Oncology (G100) and NCT E-mail
Prof. Dr. Ana MARTIN-VILLALBA, Division of Neurobiology of Brain Tumors (G381) E-mail
Dr. Ali NOWROUZI, Division of Translational Oncology (G100) and NCT E-mail
Dr. Anna PARUZYNSKI, Division of Translational Oncology (G100) and NCT E-mail
Dr. Manfred SCHMIDT, Division of Translational Oncology (G100) and NCT E-mail
Prof. Dr. Viktor UMANSKY, Clinical Cooperation Unit for Dermato-Oncology (G300) E-mail
Dr. Dr. Guy UNGERECHTS, Division of Translational Oncology (G100) and NCT E-mail
For a complete overview of all DKFZ research divisions and groups:
How to become a Major Cancer Biology Faculty Member?
If you are DKFZ scientist or cooperative partner and wish to actively contribute to our study program by, e.g., giving lectures or tutorials, by organizing (part of) a HP-F practical, please contact the Coordinator, Prof. Ilse Hofmann, to discuss how your offer can be integrated to the program. We are always happy to welcome new active contributors!
In certain cases, teaching activities at the Bachelor level can also be honored by becoming a Major Cancer Biology faculty member.
